Clinical Trials Browser

INDUSTRY × Has results × trastuzumab duocarmazine × Clear all

NCT04205630 2024-05-30

SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma

Phase 2 Completed

64 enrolled 13 charts

Endometrial Neoplasms

NCT03262935 2023-10-19

TULIP

Phase 3 Completed

437 enrolled 17 charts

Breast Neoplasms